Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

NCT06116903 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT06116903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06116903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes
Lead sponsor
University Hospital, Limoges
Phase
Not applicable
Overall status
Recruiting
Start date
April 11, 2024
Completion date
December 15, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma